Status: Recruiting
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
A Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants with or without Type 2 Diabetes
Participants needed: 180
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Alveus Therapeutics, Inc.Updated: May 22, 2026Locations: 2
Eligibility criteria
Adult male and female participants, aged 18 to 65 years, inclusive, at the time... [+7]
History or presence of any clinically relevant respiratory, metabolic (including... [+12]